Measles vaccination of young infants in China: A cost-effectiveness analysis.

CONCLUSION: We found potential beneficial health gains at a minimum cost associated with adding an earlier measles dose <8 months of age in China. Further investigation about disease transmission dynamics is required to more fully assess the tradeoffs of administering measles at a younger age to infants in China. PMID: 32451210 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32451210?dopt=Abstract

Source: Vaccine - May 21, 2020 Category: Allergy & Immunology Authors: Janusz CB, Wagner AL, Masters NB, Ding Y, Zhang Y, Hutton DW, Boulton ML Tags: Vaccine Source Type: research